Selective Antimicrobial Modulation of the Intestinal Flora. Prophylaxis Against Infection in Neutropenic Patients

Overview

Journal Infection

Date 1984 Jan 1

PMID 6423548

Citations 7

Authors

H F Guiot

R Van Furth

Affiliations

Soon will be listed here.

Citing Articles

Antibiotic prophylaxis in children with cancer or who have undergone hematopoietic cell transplantation.

Cecinati V, Principi N, Brescia L, Esposito S Eur J Clin Microbiol Infect Dis. 2013; 33(1):1-6.

PMID: 23884866 DOI: 10.1007/s10096-013-1932-7.

Kinetics of endotoxin and tumor necrosis factor appearance in portal and systemic circulation after hemorrhagic shock in rats.

Jiang J, Bahrami S, Leichtfried G, Redl H, Ohlinger W, Schlag G Ann Surg. 1995; 221(1):100-6.

PMID: 7826148 PMC: 1234500. DOI: 10.1097/00000658-199501000-00012.

Selective decontamination and the anaerobic faecal flora.

Hazenberg M Antonie Van Leeuwenhoek. 1984; 50(5-6):683-9.

PMID: 6397135 DOI: 10.1007/BF02386233.

Binding to and antibacterial effect of aztreonam, temocillin, gentamicin and tobramycin on human faeces.

Hazenberg M, van de Merwe J J Hyg (Lond). 1985; 95(2):255-63.

PMID: 4067288 PMC: 2129534. DOI: 10.1017/s0022172400062689.

New selective medium for Pseudomonas aeruginosa with phenanthroline and 9-chloro-9-[4-(diethylamino)phenyl]-9,10-dihydro-10- phenylacridine hydrochloride (C-390).

CAMPBELL M, Farmer S, Speert D J Clin Microbiol. 1988; 26(9):1910-2.

PMID: 3141474 PMC: 266749. DOI: 10.1128/jcm.26.9.1910-1912.1988.

References

Dietrich M, Gaus W, Vossen J, Van Der Waaij D, Wendt F . Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results. Infection. 1977; 5(2):107-14. DOI: 10.1007/BF01642091. View

BENDER J, Schimpff S, YOUNG V, Fortner C, Brouillet M, Love L . Role of vancomycin as a component of oral nonabsorbable antibiotics for microbial suppression in leukemic patients. Antimicrob Agents Chemother. 1979; 15(3):455-60. PMC: 352683. DOI: 10.1128/AAC.15.3.455. View

Dekker A, Rozenberg-Arska M, Sixma J, Verhoef J . Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia. Ann Intern Med. 1981; 95(5):555-9. DOI: 10.7326/0003-4819-95-5-555. View

Van Der Waaij D, Berghuis J, Lekkerkerk J . Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. J Hyg (Lond). 1972; 70(4):605-10. PMC: 2130274. DOI: 10.1017/s0022172400022464. View

Kurrle E, Bhaduri S, Krieger D, Pflieger H, Heimpel H . Antimicrobial prophylaxis in acute leukaemia: prospective randomized study comparing two methods of selective decontamination. Klin Wochenschr. 1983; 61(14):691-8. DOI: 10.1007/BF01487614. View

FINLAND M, WEINSTEIN L . Complications induced by antimicrobial agents. N Engl J Med. 1953; 248(6):220-6. DOI: 10.1056/NEJM195302052480602. View

Wade J, Schimpff S, Hargadon M, Fortner C, YOUNG V, Wiernik P . A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med. 1981; 304(18):1057-62. DOI: 10.1056/NEJM198104303041801. View

Bohnhoff M, Miller C, Martin W . RESISTANCE OF THE MOUSE'S INTESTINAL TRACT TO EXPERIMENTAL SALMONELLA INFECTION. I. FACTORS WHICH INTERFERE WITH THE INITIATION OF INFECTION BY ORAL INOCULATION. J Exp Med. 1964; 120:805-16. PMC: 2137858. DOI: 10.1084/jem.120.5.805. View

Storring R, Jameson B, McElwain T, Wiltshaw E . Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia. Lancet. 1977; 2(8043):837-40. DOI: 10.1016/s0140-6736(77)90779-6. View

10.

Guiot H, van den Broek P, van der Meer J, Van Furth R . Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study. J Infect Dis. 1983; 147(4):615-23. DOI: 10.1093/infdis/147.4.615. View

11.

Guiot H, van der Meer J, Van Furth R . Prophylactic co-trimoxazole in leukaemia. Lancet. 1978; 2(8091):678. DOI: 10.1016/s0140-6736(78)92786-1. View

12.

Sleijfer D, Mulder N, de Vries-Hospers H, Fidler V, NIEWEG H, Van Der Waaij D . Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer (1965). 1980; 16(6):859-69. DOI: 10.1016/0014-2964(80)90140-1. View

13.

Levine A, Siegel S, Schreiber A, Hauser J, Preisler H, Goldstein I . Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med. 1973; 288(10):477-83. DOI: 10.1056/NEJM197303082881001. View

14.

Guiot H . Role of competition for substrate in bacterial antagonism in the gut. Infect Immun. 1982; 38(3):887-92. PMC: 347832. DOI: 10.1128/iai.38.3.887-892.1982. View

15.

Levitan A, Perry S . The use of an isolator system in cancer chemotherapy. Am J Med. 1968; 44(2):234-42. DOI: 10.1016/0002-9343(68)90155-1. View

16.

Michaelsen G, Vesley D, Halbert M . Laminar flow studied as aid in care of low-resistance patients. Hospitals. 1967; 41(12):91-106. View

17.

Preisler H, Bruckner H, HENDERSON E . Reduced production of spleen colonies and granulocytes in antibiotic-treated irradiated mice transplanted with syngeneic bone marrow. Radiat Res. 1971; 48(1):20-31. View

18.

Bodey G, Rodriguez V, Chang H, Narboni . Fever and infection in leukemic patients: a study of 494 consecutive patients. Cancer. 1978; 41(4):1610-22. DOI: 10.1002/1097-0142(197804)41:4<1610::aid-cncr2820410452>3.0.co;2-b. View

19.

LEVENSON S, TREXLER P, LACONTE M, PULASKI E . APPLICATION OF THE TECHNOLOGY OF THE GERMFREE LABORATORY TO SPECIAL PROBLEMS OF PATIENT CARE. Am J Surg. 1964; 107:710-22. DOI: 10.1016/0002-9610(64)90298-3. View

20.

. Infection prevention in acute leukaemia. Lancet. 1978; 2(8093):769-70. View